Global Gastroparesis Market, By Type (Idiopathic, Diabetic, Post- Surgical and Others), Drug Class (Prokinetic Drugs, Antiemetics, Botulinum Toxin Injection, Antidepressants and Others), Treatment (Jejunostomy, Gastric Electric Stimulation, Parenteral Nutrition, Diabetic Gastroparesis, Chronic Gastroparesis, Idiopathic Gastroparesis and Post-Operative Gastroparesis), Distribution Channel (Retail Pharmacies, Hospital Pharmacies and Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Gastroparesis Market
The gastroparesis market is expected to witness market growth at a rate of 4.8% in the forecast period of 2021 to 2028 and is further estimated to reach USD 8,191.53 million by 2028. Data Bridge Market Research report on gastroparesis market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the number of surgeries is escalating the growth of gastroparesis market.
Gastroparesis can be referred to as a condition in which the muscles of the stomach don’t function accurately. The disease influences the movement of the muscle in stomach because of which they are not able to empty them accurately. The disease can disturb the blood sugar level and nutrition and can also cause vomiting and nausea.
Major factors that are expected to boost the growth of the gastroparesis market in the forecast period are the rise in the prevalence of idiopathic gastroparesis. Furthermore, the increase in the surgeries can cause post-operative gastroparesis is further anticipated to propel the growth of the gastroparesis market. Moreover, the rise in the research and development by producer for more advanced drug for the treatment of gastroparesis is further estimated to cushion the growth of the gastroparesis market. On the other hand, the difficulties related to the harmful effects of the gastroparesis drugs are further projected to impede the growth of the gastroparesis market in the timeline period.
In addition, the increase in the incidence of diabetes mellitus amongst population will further provide potential opportunities for the growth of the gastroparesis market in the coming years. However, the stringent guidelines for the approval of new drugs might further challenge the growth of the gastroparesis market in the near future.
The gastroparesis market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the gastroparesis market scenario contact Data bridge market research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Gastroparesis Market Scope and Market Size
The gastroparesis medicine market is segmented on the basis of type, treatment, drug class, and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the gastroparesis market is segmented into idiopathic, diabetic, post- surgical and others.
- On the basis of treatment, the gastroparesis market is segmented into jejunostomy, gastric electric stimulation, parenteral nutrition, diabetic gastroparesis, chronic gastroparesis, idiopathic gastroparesis and post-operative gastroparesis.
- On the basis of drug class, the gastroparesis market is segmented into jejunostomy, gastric electric stimulation, parenteral nutrition, diabetic gastroparesis, chronic gastroparesis, idiopathic gastroparesis and post-operative gastroparesis.
- On the basis of distribution channel, the gastroparesis market is segmented into retail pharmacies, hospital pharmacies and others.
Gastroparesis Market Country Level Analysis
The gastroparesis market is analysed and market size information is provided by country, type, drug class, treatment and distribution channel as referenced above.
The countries covered in the gastroparesis market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the gastroparesis market due to the increase in the number of diabetic patients. Furthermore, the diabetic gastroparesis is considered one of the major procedures of gastroparesis that is affecting the population will further boost the growth of the gastroparesis market in the region during the forecast period. Asia-Pacific is projected to observe the growth in the gastroparesis market due to the rise in the standard pace of diabetes. Moreover, the vast untapped market potential amongst the advancing countries is further anticipated to propel the growth of the gastroparesis market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The gastroparesis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Gastroparesis Market Share Analysis
The gastroparesis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to gastroparesis market.
The major players covered in the gastroparesis market report are Medtronic, Neurogastrx, Inc., Endologic, Takeda Pharmaceutical Company Limited., ALLERGAN, Theravance Biopharma, Evoke Pharma, CAIRN DIAGNOSTICS, Lupin Pharmaceuticals Inc., Thermo Fisher Scientific, Amneal Pharmaceuticals LLC, Annora Pharma Pvt, Bristol-Myers Squibb Company, bioMérieux, Inc, Bio-Rad Laboratories, Inc, Abbott, AbbVie Inc, Pfizer Inc, Bayer AG, and Novartis AG, among other domestic and global players. Gastroparesis market market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-